Capital Performance Advisors »

Stoke Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $392 32 12.28

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Stoke Therapeutics

Skorpios Trust
BlackRock
BlackRock
Lynx1 Capital Management
Redmile Group
Baker Bros. Advisors
Morgan Stanley
Cowen And Company
Vanguard Group
Marshall Wace
State Street Corporation
Goldman Sachs Group
Assenagon Asset Management
Logos Global Management
Geode Capital Management

View all funds holding Stoke Therapeutics